IQVIA Quarterly Income Statement
NYSE: IQVHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:02 PM ET · Delayed 15 min
IQVIA revenue and earnings
In the quarter ended Mar 31, 2026, IQVIA generated $4.15 billion in revenue, up 8.4% from the same quarter a year earlier. Net income was $274.0 million (+10.0% year over year), for a net margin of 6.6% versus a median of 8.1% in the prior 5 quarters. Gross margin was 32.6% (down from 33.9%) and operating margin 12.4%.
Diluted earnings per share came in at $1.61, up from $1.40.
Summary generated from market data by MetaCap's automated system. Methodology
IQVIA income statement (quarterly)
| Quarter (USD) | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 | Q2 20232023-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.15B | 4.36B | 4.10B | 4.02B | 3.83B | 3.96B | 3.90B | 3.81B | 3.74B | 3.87B | 3.74B | 3.73B |
| Revenue growth (YoY) | +8.41% | +10.26% | +5.24% | +5.32% | +2.46% | +2.33% | +4.28% | +2.31% | +2.33% | +3.45% | +4.88% | +5.28% |
| Cost of Revenue | 2.80B | 2.93B | 2.73B | 2.69B | 2.53B | 2.58B | 2.52B | 2.49B | 2.44B | 2.48B | 2.43B | 2.44B |
| Gross Profit | 1.35B | 1.44B | 1.37B | 1.32B | 1.30B | 1.38B | 915.00M | 863.00M | 827.00M | 1.39B | 862.00M | 850.00M |
| Operating Expenses | 841.00M | 809.00M | 820.00M | 817.00M | 802.00M | 752.00M | 365.00M | 343.00M | 321.00M | 889.00M | 381.00M | 326.00M |
| Selling, General & Admin | 502.00M | 468.00M | 514.00M | 509.00M | 508.00M | 453.00M | 522.00M | 509.00M | 508.00M | 556.00M | 502.00M | 482.00M |
| Operating Income | 514.00M | 627.00M | 553.00M | 506.00M | 496.00M | 626.00M | 550.00M | 520.00M | 506.00M | 501.00M | 481.00M | 524.00M |
| Interest Expense | 192.00M | 193.00M | 189.00M | 182.00M | 165.00M | 171.00M | 170.00M | 163.00M | 166.00M | 181.00M | 181.00M | 169.00M |
| Other Income (Expense) | -4.00M | 94.00M | 31.00M | -11.00M | -15.00M | 78.00M | -44.00M | 67.00M | -11.00M | 47.00M | 35.00M | 16.00M |
| Pretax Income | 328.00M | 537.00M | 408.00M | 323.00M | 323.00M | 544.00M | 349.00M | 436.00M | 340.00M | 373.00M | 349.00M | 375.00M |
| Income Tax | 59.00M | 59.00M | 76.00M | 56.00M | 61.00M | 112.00M | 65.00M | 75.00M | 49.00M | -102.00M | 51.00M | 81.00M |
| Net Income | 274.00M | 514.00M | 331.00M | 266.00M | 249.00M | 437.00M | 285.00M | 363.00M | 288.00M | 469.00M | 303.00M | 297.00M |
| Net Income growth (YoY) | +10.04% | +17.62% | +16.14% | -26.72% | -13.54% | -6.82% | -5.94% | +22.22% | -0.35% | +106.61% | +7.07% | +16.02% |
| EPS (Basic) | 1.63 | 3.00 | 1.94 | 1.55 | 1.42 | 2.43 | 1.57 | 1.99 | 1.58 | 2.56 | 1.66 | 1.61 |
| EPS (Diluted) | 1.61 | 2.97 | 1.93 | 1.54 | 1.40 | 2.41 | 1.55 | 1.97 | 1.56 | 2.54 | 1.63 | 1.59 |
| Shares Outstanding (Basic) | 168.40M | — | 170.20M | 171.80M | 175.70M | — | 182.10M | 182.20M | 181.90M | — | 182.90M | 184.40M |
| Shares Outstanding (Diluted) | 169.80M | — | 171.70M | 173.20M | 177.40M | — | 184.20M | 184.30M | 184.30M | — | 185.50M | 186.70M |
| EBITDA | 802.00M | 944.00M | 839.00M | 782.00M | 761.00M | 929.00M | 828.00M | 789.00M | 770.00M | 817.00M | 778.00M | 783.00M |
| Gross Margin | 32.64% | 32.91% | 33.49% | 32.94% | 33.90% | 34.82% | 23.49% | 22.63% | 22.13% | 35.94% | 23.07% | 22.80% |
| Operating Margin | 12.38% | 14.37% | 13.49% | 12.60% | 12.95% | 15.82% | 14.12% | 13.63% | 13.54% | 12.95% | 12.87% | 14.06% |
| Net Margin | 6.60% | 11.78% | 8.07% | 6.62% | 6.50% | 11.04% | 7.32% | 9.52% | 7.71% | 12.13% | 8.11% | 7.97% |
This table shows 12 quarterly periods of IQVIA's income statement, from Q1 2026 back to Q2 2023, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow IQV's reporting calendar. What is a income statement?